This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CLINICAL AND EXPERIMENTAL RESULTS

JACOB JACOBSON, M.D.

Arch Ophthal. 1936;16(3):400-404.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1919 I introduced the use of benzyl cinnamate in the treatment of tuberculosis. In order to inquire into the efficacy of this drug against tuberculosis, I used it first in the treatment of external forms of the disease, such as tuberculosis of the skin, mucous membranes and glands. These lesions being visible, it was easy to control and to follow the course of the disease. The results obtained proved worthy of interest and were confirmed by Darier and Jeanselme.¹ My subsequent researches showed that the therapeutic action of the drug is not specific for tuberculosis. Its action can be seen wherever a focus of chronic inflammation is found, regardless of the nature of the agent which produces the lesion.

It was by pure chance that benzyl cinnamate found its application in the field of ophthalmology. While treating an Algerian Arab for glandular tuberculosis, I observed that while . . . [Full Text PDF of this Article]

Author Affiliations
PARIS, FRANCE

Footnotes
Presented before the New York Academy of Medicine, Section of Ophthalmology, Feb. 17, 1936.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?